Accuracy of carbapenem nonsusceptibility for identification of KPC-possessing Enterobacteriaceae by use of the revised CLSI breakpoints

Journal of Clinical Microbiology

Volumn 49, Issue 11, 2011, Pages 3931-3933

  Landman, David ^a   Salamera, Julius ^a   Singh, Manisha ^a   Quale, John ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; BETA LACTAMASE KPC; CARBAPENEM; CEFTAZIDIME; ERTAPENEM; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; UNCLASSIFIED DRUG;

ACCURACY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CONTROLLED STUDY; ENTEROBACTER; ENTEROBACTERIACEAE; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CARBAPENEMS; ENTEROBACTERIACEAE; HUMANS; MICROBIAL SENSITIVITY TESTS; SENSITIVITY AND SPECIFICITY;

ENTEROBACTER; ENTEROBACTERIACEAE; ESCHERICHIA COLI;

EID: 80355126233     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01176-11     Document Type: Article

References (21)

1. Anderson, K. F., et al. 2007. Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae. J. Clin. Microbiol. 45:2723-2725. (Pubitemid 47295515)
2. Bratu, S., et al. 2005. Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection. Antimicrob. Agents Chemother. 49:3018-3020. (Pubitemid 40917631)
3. Bulik, C. C., et al. 2010. Comparison of meropenem MICs and susceptibilities for carbapenemase-producing Klebsiella pneumoniae isolates by various testing methods. J. Clin. Microbiol. 48:2402-2406.
4. CLSI. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 7th edition. Approved standard M7-A7. CLSI, Wayne, PA.
5. CLSI. 2010. Performance standards for antimicrobial susceptibility testing; 20th information supplement (June 2010 update). M100-S20. CLSI, Wayne, PA.
6. Doern, C. D., W. M. Dunne, Jr., and C.-A. D. Burnham. 2011. Detection of Klebsiella pneumoniae carbapenemase (KPC) production in non-Klebsiella pneumoniae Enterobacteriaceae isolates by use of the Phoenix, Vitek 2, and disk diffusion methods. J. Clin. Microbiol. 49:1143-1147.
7. Doumith, M., M. J. Ellington, D. M. Livermore, and N. Woodford. 2009. Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK. J. Antimicrob. Chemother. 63:659-667.
8. Endimiani, D., et al. 2009. Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA. J. Antimicrob. Chemother. 63:427-437.
9. Endimiani, A., et al. 2010. Evaluation of updated interpretative criteria for categorizing Klebsiella pneumoniae with reduced carbapenem susceptibility. J. Clin. Microbiol. 48:4417-4435.
10. Kitchel, B., et al. 2010. Genetic factors associated with elevated carbapenem resistance in KPC-producing Klebsiella pneumoniae. Antimicrob. Agents Chemother. 54:4201-4207.
11. Landman, D., et al. 2007. Evolution of antimicrobial resistance among Pseudomonas aeruginosa, Acinetobacter baumannii, and Klebsiella pneumoniae in Brooklyn, NY. J. Antimicrob. Chemother. 60:78-82. (Pubitemid 47073279)
12. Landman, D., S. Bratu, and J. Quale. 2009. Contribution of OmpK36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniae. J. Med. Microbiol. 58:1303-1308.
13. Landman, D., et al. 2010. Susceptibility profiles, molecular epidemiology, and detection of KPC-producing Escherichia coli isolates from the New York City vicinity. J. Clin. Microbiol. 48:4604-4607.
14. Marchaim, D., S. Navon-Venezia, M. J. Schwaber, and Y. Carmeli. 2008. Isolation of imipenem-resistant Enterobacter species: emergence of KPC-2 carbapenemase, molecular characterization, epidemiology, and outcomes. Antimicrob. Agents Chemother. 52:1413-1418. (Pubitemid 351522007)
15. Marschall, J., et al. 2009. Presence of the KPC carbapenemase gene in Enterobacteriaceae causing bacteremia and its correlation with in vitro carbapenem susceptibility. J. Clin. Microbiol. 47:239-241.
16. McGettigan, S. E., K. Andreacchi, and P. H. Edelstein. 2009. Specificity of ertapenem susceptibility screening for detection of Klebsiella pneumoniae carbapenemases. J. Clin. Microbiol. 47:785-786.
17. Pasteran, F., C. Lucero, R. Solaga, M. Rapoport, and A. Corso. 2011. Can we use imipenem and meropenem Vitek 2 MICs for detection of suspected KPC and other-carbapenemase producers among species of Enterobacteriaceae? J. Clin. Microbiol. 49:697-701.
18. Paterson, D. L., et al. 2003. Extended-spectrum β-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV- and CTX-M-type β-lactamases. Antimicrob. Agents Chemother. 47:3554-3560. (Pubitemid 37345719)
19. Tenover, F. C., et al. 2006. Carbapenem resistance in Klebsiella pneumoniae not detected by automated susceptibility testing. Emerg. Infect. Dis. 12:1209-1213.
20. Woodford, N., et al. 2007. Ertapenem resistance among Klebsiella and Enterobacter submitted in the UK to a reference laboratory. Int. J. Antimicrob. Agents 29:456-459. (Pubitemid 46349596)
21. Woodford, N., E. J. Fagan, and M. J. Ellington. 2006. Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum β-lactamases. J. Antimicrob. Chemother. 57:154-155. (Pubitemid 43057077)